Market Research Report

Healthcare, Regulatory and Reimbursement Landscape Vietnam
cover Published by GlobalData
Published Product code 244982
Content info Pages: 144
Price

Introduction

Abstract

Healthcare, Regulatory and Reimbursement Landscape - Vietnam

Summary

GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - Vietnam". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of Vietnam. It identifies the key trends in the healthcare market of Vietnam and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the country. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

The population of Vietnam was approximately 86.5 million in 2010, making it the 13th most populated country in the world. This increase in the population is primarily due to a high birth rate and an increase in life expectancy. An increasing disease burden is a matter of concern for policy planners in Vietnam. The pharmaceutical market in the country was $1.9 billion in 2010 and is expected to reach approximately $5.8 billion by 2020 at a projected CAGR of 12%.

The positive trend in the healthcare market of Vietnam can be primarily attributed to -

  • Increasing coverage of public health insurance in the country
  • High expenditure on healthcare
  • Government initiatives for the prevention and management of chronic diseases
  • An improved and updated regulatory environment

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape of Vietnam. The scope of the report includes -

  • An overview of the pharmaceutical market of Vietnam including market size and market segmentation, as well as key drivers and barriers.
  • Profile and SWOT analysis of the major players in the pharmaceutical market. The key players covered are Vinapharm, Pfizer, Sanofi, Novartis and Merck & Co.
  • An insightful review of the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, regulatory agencies and the market authorization process for a new drug and medical devices in Vietnam.
  • A detailed analysis of the political and economic environment of Vietnam including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
  • An overview of the opportunities and challenges for growth that exist in the healthcare market of Vietnam.

Reasons to buy

This report comprehensively covers the pharmaceutical market of Vietnam. It will enhance your decision making capability and will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the healthcare market of Vietnam.
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the Vietnamese healthcare market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the maximum opportunities for consolidations, investments and strategic partnerships.
  • Identify, understand and capitalize on the opportunities and challenges in the healthcare market of Vietnam.

Table of Contents

TOC

1 Table of Contents

1 Table of Contents 4

  • 1.1 List of Tables 6
  • 1.2 List of Figures 7

2 Introduction 9

  • 2.1 Report Guidance 9

3 Overview of the Pharmaceutical and Medical Device Markets 10

  • 3.1 Pharmaceutical Market 10
    • 3.1.1 Market Overview 10
    • 3.1.2 Supply Channels 14
    • 3.1.3 Market Segments 15
    • 3.1.4 Overview of Major Disease Areas 18
    • 3.1.5 Major Players 20
  • 3.2 Medical Device Market 47
  • 3.3 Market Drivers and Barriers 47
    • 3.3.1 Drivers 47
    • 3.3.2 Barriers 48

4 Market Access 50

  • 4.1 Reimbursement and Payer Landscape 50
    • 4.1.1 Overview of Healthcare System 50
    • 4.1.2 Reimbursement Process 51
    • 4.1.3 Overview of Insurance Providers 52
    • 4.1.4 Patient Share in Healthcare Spending 56
    • 4.1.5 Drug Price Trend 57
    • 4.1.6 Pricing Policies 58
  • 4.2 Regulatory Landscape 58
    • 4.2.1 Overview of Regulatory Agencies 58
    • 4.2.2 New Drug Approval Process 59
    • 4.2.3 Drug Registration Process for Generics 61
    • 4.2.4 Licensing Process for Pharmaceutical Manufacturing 64
    • 4.2.5 Licensing Process for Pharmaceutical Exports and Imports 64
    • 4.2.6 Intellectual Property Rights 65
    • 4.2.7 Clinical Trial Regulations 69
    • 4.2.8 Pharmaceutical Advertising Regulations 70
    • 4.2.9 Pharmacy Regulations 71
    • 4.2.10 Labeling and Packaging Regulations 72

5 Country Analysis 74

  • 5.1 Political Environment 74
    • 5.1.1 Political Structure 74
    • 5.1.2 Analysis of the Current Political Environment 74
    • 5.1.3 Healthcare Policy Initiatives 75
  • 5.2 Economic Landscape 76
  • 5.3 Economic Indicators 77
    • 5.3.1 Gross Domestic Product 77
    • 5.3.2 Gross National Income 83
    • 5.3.3 Inflation 84
    • 5.3.4 Currency Exchange Rate 88
    • 5.3.5 Foreign Direct Investment 89
    • 5.3.6 Foreign Exchange Reserves 90
    • 5.3.7 Trade Balance 91
    • 5.3.8 Fiscal Deficit 93
    • 5.3.9 General Government Net Debt 94
    • 5.3.10 External Debt 96
    • 5.3.11 Major Industries 97
  • 5.4 Demographics 98
    • 5.4.1 Population 98
    • 5.4.2 Education and Literacy 116
    • 5.4.3 Employment 117
    • 5.4.4 Disease Burden 118
  • 5.5 Healthcare Infrastructure 120
    • 5.5.1 Healthcare Facilities 120
    • 5.5.2 Healthcare Parameters 123
    • 5.5.3 Environmental Health 125
    • 5.5.4 Healthcare Personnel 128
  • 5.6 Healthcare Expenditure 129
    • 5.6.1 Overview 129
    • 5.6.2 Major Components of Healthcare Spending 130
    • 5.6.3 Public and Private Sector Shares 131
  • 5.7 Trade Associations 132
  • 5.8 Trade Fairs 133

6 Opportunities and Challenges 134

  • 6.1 Opportunities 134
  • 6.2 Challenges 134

7 Appendix 136

  • 7.1 Abbreviations 136
  • 7.2 Bibliography 138
  • 7.3 Methodology 142
    • 7.3.1 Coverage 142
    • 7.3.2 Secondary Research 142
    • 7.3.3 Forecasting 143
    • 7.3.4 Primary Research 143
    • 7.3.5 Expert Panel Validation 143
  • 7.4 Contact Us 143
  • 7.5 Disclaimer 144

List of Tables

1.1 List of Tables

  • Table 1: Pharmaceutical Market ($bn), Vietnam, 2005-2010 11
  • Table 2: Pharmaceutical Market ($bn), Vietnam, 2011-2020 12
  • Table 3: Pharmaceutical Market ($bn), Vietnam, Imports Share (%), 2005-2010 13
  • Table 4: Over-the-Counter Pharmaceutical, Vietnam, Major Segments Share (%), 2010 17
  • Table 5: Mental Disorders, Prevalence (%), Vietnam, 2003 19
  • Table 6: Major Products, Vinapharm, Global, 2012 21
  • Table 7: Major Products, Pfizer, Global, Revenue ($m), 2011 24
  • Table 8: Late-stage Pipeline, Pfizer, 2012 24
  • Table 9: Major Products, Sanofi, Global, Revenue ($m), 2011 29
  • Table 10: Late-stage Pipeline, Sanofi, 2012 29
  • Table 11: Major Products, Novartis, Global, Revenue ($m), 2011 34
  • Table 12: Planned Filings, Novartis, 2012 to ≥ 2016 35
  • Table 13: Major Products, Merck & Co, Global, Revenue ($m), 2011 41
  • Table 14: Late-stage Pipeline, Merck & Co, 2012 41
  • Table 15: Health Insurance Coverage, Population (%), Vietnam, 2005-2010 53
  • Table 16: Health Insurance Coverage, Insured Population (m), Vietnam, 2005-2010 54
  • Table 17: Healthcare Spending, Vietnam, Patient's Share (%), 2005-2010 56
  • Table 18: Healthcare Spending, Vietnam, Price Change (%), 2006-2011 57
  • Table 19: List of the Generic Drugs Required to Submit BE/BA at the Time of Approval, Vietnam, 2012 62
  • Table 20: Labeling Guidelines, Vietnam, 2012 72
  • Table 21: GDP ($bn), Vietnam, 2006-2011 77
  • Table 22: GDP ($bn), Vietnam, Forecast, 2012-2020 78
  • Table 23: GDP Per Capita ($), Vietnam, 2005-2010 79
  • Table 24: GDP Per Capita ($), Vietnam, Forecast, 2011-2020 80
  • Table 25: GDP, Vietnam, Annual Growth (%), 2006-2011 81
  • Table 26: GDP, Vietnam, Annual Growth (%), 2012-2020 82
  • Table 27: GNI Per Capita ($), Vietnam, 2005-2010 83
  • Table 28: Average Consumer Price Index, Vietnam, 2006-2011 84
  • Table 29: Average Consumer Price Index, Vietnam, 2012-2020 85
  • Table 30: Average Consumer Price, Vietnam, Annual Change (%), 2006-2011 86
  • Table 31: Average Consumer Price, Vietnam, Annual Change (%), 2012-2020 87
  • Table 32: Currency Exchange Rate (VND/$), Vietnam, 2005-2010 88
  • Table 33: Foreign Direct Investment ($bn), Vietnam, 2005-2010 89
  • Table 34: Foreign Exchange Reserves ($bn), Vietnam, 2005-2010 90
  • Table 35: Export of Goods and Services ($bn), Vietnam, 2005-2010 91
  • Table 36: Import of Goods and Services ($bn), Vietnam, 2005-2010 92
  • Table 37: Fiscal Deficit (% of GDP), Vietnam, 2006-2011 93
  • Table 38: General Government Net Debt (% of GDP), Vietnam, 2006-2011 94
  • Table 39: General Government Net Debt (% of GDP), Vietnam, Forecast, 2012-2020 95
  • Table 40: External Debt (% of GDP), Vietnam, 2005-2010 96
  • Table 41: Major Industries, Vietnam, Gross Output ($bn), 2005 and 2010 97
  • Table 42: Population (m), Vietnam, 2005-2010 98
  • Table 43: Population (m), Vietnam, Forecast, 2011-2020 99
  • Table 44: Urban and Rural Population, Vietnam, Share (%), 2005-2010 100
  • Table 45: Urban and Rural Population, Vietnam, Share (%), Forecast, 2011-2020 101
  • Table 46: Age Groups, Vietnam, Population Distribution (%), 2005-2010 102
  • Table 47: Age Groups, Vietnam, Population Distribution (%), Forecast, 2011-2020 103
  • Table 48: Births (Per 1,000 Population), Vietnam, 2005-2010 104
  • Table 49: Births (Per 1,000 Population), Vietnam, 2011-2020 105
  • Table 50: Mortality (Per 1,000 Population), Vietnam, 2005-2010 106
  • Table 51: Major Causes of Mortality ('000s), Vietnam, 2008 107
  • Table 52: Children <5 Years Age, Vietnam, Mortality (Per 1,000 Live Births), 2005-2010 108
  • Table 53: Immunization Rate for Measles and DPT (%), Vietnam, 2005-2010 109
  • Table 54: Major Causes of Male Mortality ('000s), Vietnam, 2008 110
  • Table 55: Major Causes of Female Mortality ('000s), Vietnam, 2008 111
  • Table 56: Gender Ratio (M/F), Vietnam, 2005-2010 112
  • Table 57: Gender Ratio (M/F), Vietnam, Forecast, 2011-2020 113
  • Table 58: Life Expectancy at Birth (Years), Vietnam, 2005-2010 114
  • Table 59: Life Expectancy at Birth (Years), Vietnam, Forecast, 2011-2020 115
  • Table 60: Students, Vietnam, Gross Enrollment (%), 2005-2010 116
  • Table 61: Unemployment Rate (%), Vietnam, 2005-2010 117
  • Table 62: Major Diseases, Vietnam, Prevalence (%), 2010 118
  • Table 63: Major Diseases, Vietnam, DALY (Per 100,000 Population), 2004 119
  • Table 64: Health Establishments, Vietnam, 2006-2011 121
  • Table 65: Beds by Type of Establishment, Vietnam, 2006-2011 122
  • Table 66: Hospital Beds (per 1,000 Population), Vietnam, 2006-2011 123
  • Table 67: Physicians (per 100,000 Population), Vietnam, 2005-2010 124
  • Table 68: PM10 (Micrograms per Cubic Meter), Vietnam, 2005-2010 125
  • Table 69: CO2 (Metric Tons), Vietnam, 2005-2010 126
  • Table 70: Healthcare Personnel (per 100,000 Population), Vietnam, 2005-2010 128
  • Table 71: Healthcare Expenditure (% of GDP), Vietnam, 2005-2010 129
  • Table 72: Healthcare Expenditure, Vietnam, Share of Major Components (%), 2007 130
  • Table 73: Healthcare Expenditure, Vietnam, Public-Private Share (%), 2005-2010 131
  • Table 74: Major Healthcare Trade Fairs, Vietnam 133

List of Figures

1.2 List of Figures

  • Figure 1: Pharmaceutical Market ($bn), Vietnam, 2005-2010 11
  • Figure 2: Pharmaceutical Market ($bn), Vietnam, 2011-2020 12
  • Figure 3: Pharmaceutical Market ($bn), Vietnam, Imports Share (%), 2005-2010 13
  • Figure 4: Supply Channel, Vietnam, 2012 14
  • Figure 5: Over-the-Counter Pharmaceutical, Vietnam, Major Segments Share (%), 2010 17
  • Figure 6: Drivers and Barriers, Healthcare Market, Vietnam, 2012 49
  • Figure 7: Healthcare System, Vietnam, 2012 50
  • Figure 8: Funding to Healthcare System, Vietnam, 2012 52
  • Figure 9: Health Insurance Coverage, Population (%), Vietnam, 2005-2010 53
  • Figure 10: Health Insurance Coverage, Insured Population (m), Vietnam, 2005-2010 54
  • Figure 11: Evolution of Health Insurance Coverage, Vietnam, 1992-2014 55
  • Figure 12: Healthcare Spending, Vietnam, Patient's Share (%), 2005-2010 56
  • Figure 13: Healthcare Spending, Vietnam, Price Change (%), 2006-2011 57
  • Figure 14: New Drug Approval Process, Vietnam, 2012 61
  • Figure 15: Generic Drug Approval Process, Vietnam, 2012 63
  • Figure 16: Patent and Trademark Approval Process, Vietnam, 2012 68
  • Figure 17: GDP ($bn), Vietnam, 2006-2011 77
  • Figure 18: GDP ($bn), Vietnam, Forecast, 2012-2020 78
  • Figure 19: GDP Per Capita ($), Vietnam, 2005-2010 79
  • Figure 20: GDP Per Capita ($), Vietnam, Forecast, 2011-2020 80
  • Figure 21: GDP, Vietnam, Annual Growth (%), 2006-2011 81
  • Figure 22: GDP, Vietnam, Annual Growth (%), 2012-2020 82
  • Figure 23: GNI Per Capita ($), Vietnam, 2005-2010 83
  • Figure 24: Average Consumer Price Index, Vietnam, 2006-2011 84
  • Figure 25: Average Consumer Price Index, Vietnam, 2012-2020 85
  • Figure 26: Average Consumer Price, Vietnam, Annual Change (%), 2006-2011 86
  • Figure 27: Average Consumer Price, Vietnam, Annual Change (%), 2012-2020 87
  • Figure 28: Currency Exchange Rate (VND/$), Vietnam, 2005-2010 88
  • Figure 29: Foreign Direct Investment ($bn), Vietnam, 2005-2010 89
  • Figure 30: Foreign Exchange Reserves ($bn), Vietnam, 2005-2010 90
  • Figure 31: Export of Goods and Services ($bn), Vietnam, 2005-2010 91
  • Figure 32: Import of Goods and Services ($bn), Vietnam, 2005-2010 92
  • Figure 33: Fiscal Deficit (% of GDP), Vietnam, 2006-2011 93
  • Figure 34: General Government Net Debt (% of GDP), Vietnam, 2006-2011 94
  • Figure 35: General Government Net Debt (% of GDP), Vietnam, Forecast, 2012-2020 95
  • Figure 36: External Debt (% of GDP), Vietnam, 2005-2010 96
  • Figure 37: Major Industries, Vietnam, Gross Output ($bn), 2005 and 2010 97
  • Figure 38: Population (m), Vietnam, 2005-2010 98
  • Figure 39: Population (m), Vietnam, Forecast, 2011-2020 99
  • Figure 40: Urban and Rural Population, Vietnam, Share (%), 2005-2010 100
  • Figure 41: Urban and Rural Population, Vietnam, Share (%), Forecast, 2011-2020 101
  • Figure 42: Age Groups, Vietnam, Population Distribution (%), 2005-2010 102
  • Figure 43: Age Groups, Vietnam, Population Distribution (%), Forecast, 2011-2020 103
  • Figure 44: Births (Per 1,000 Population), Vietnam, 2005-2010 104
  • Figure 45: Births (Per 1,000 Population), Vietnam, 2011-2020 105
  • Figure 46: Mortality (Per 1,000 Population), Vietnam, 2005-2010 106
  • Figure 47: Major Causes of Mortality ('000s), Vietnam, 2008 107
  • Figure 48: Children <5 Years Age, Vietnam, Mortality (Per 1,000 Live Births), 2005-2010 108
  • Figure 49: Immunization Rate for Measles and DPT (%), Vietnam, 2005-2010 109
  • Figure 50: Major Causes of Male Mortality ('000s), Vietnam, 2008 110
  • Figure 51: Major Causes of Female Mortality ('000s), Vietnam, 2008 111
  • Figure 52: Gender Ratio (M/F), Vietnam, 2005-2010 112
  • Figure 53: Gender Ratio (M/F), Vietnam, Forecast, 2011-2020 113
  • Figure 54: Life Expectancy at Birth (Years), Vietnam, 2005-2010 114
  • Figure 55: Life Expectancy at Birth (Years), Vietnam, Forecast, 2011-2020 115
  • Figure 56: Students, Vietnam, Gross Enrollment (%), 2005-2010 116
  • Figure 57: Unemployment Rate (%), Vietnam, 2005-2010 117
  • Figure 58: Major Diseases, Vietnam, Prevalence (%), 2010 118
  • Figure 59: Major Diseases, Vietnam, DALY (per 100,000 population), 2004 119
  • Figure 60: Healthcare System, Vietnam, 2012 120
  • Figure 61: Health Establishments, Vietnam, 2006-2011 121
  • Figure 62: Beds by Type of Establishment, Vietnam, 2006-2011 122
  • Figure 63: Hospital Beds (per 1,000 Population), Vietnam, 2006-2011 123
  • Figure 64: Physicians (per 100,000 Population), Vietnam, 2005-2010 124
  • Figure 65: PM10 (Micrograms per Cubic Meter), Vietnam, 2005-2010 125
  • Figure 66: CO2 (Metric Tons), Vietnam, 2005-2010 126
  • Figure 67: Healthcare Personnel (per 100,000 Population), Vietnam, 2005-2010 128
  • Figure 68: Healthcare Expenditure (% of GDP), Vietnam, 2005-2010 129
  • Figure 69: Healthcare Expenditure, Vietnam, Share of Major Components (%), 2007 130
  • Figure 70: Healthcare Expenditure, Vietnam, Public-Private Share (%), 2005-2010 131
  • Figure 71: Opportunities and Challenges, Healthcare Market, Vietnam, 2012 135

Healthcare, Regulatory and Reimbursement Landscape Vietnam published by GlobalData in June 18, 2012. This report consists of Pages: 144 and the price starts from US $ 1995.

Back to Top